Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0R3KN
|
|||
| Former ID |
DIB002966
|
|||
| Drug Name |
MN-462
|
|||
| Synonyms |
EF-6265; CPB/TAFIa inhibitor, MediciNova; CPB/TAFIa inhibitor, Meiji Seika Kaisha/MediciNova; Carboxypeptidase B/thrombin-activated fibrinolysis inhibitor, Meiji Seika Kaisha/MediciNova
Click to Show/Hide
|
|||
| Indication | Thrombosis [ICD-11: DB61-GB90; ICD-10: I80-I82] | Investigative | [1] | |
| Company |
Meiji Seika Kaisha Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Carboxypeptidase B2 (CPB2) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Complement and coagulation cascades | |||
| Pancreatic secretion | ||||
| Protein digestion and absorption | ||||
| Panther Pathway | Plasminogen activating cascade | |||
| Reactome | Metabolism of Angiotensinogen to Angiotensins | |||
| WikiPathways | Complement and Coagulation Cascades | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1594). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.